Literature DB >> 33746444

Higher Levels of Fibrosis in a Cohort of Veterans with Chronic Viral Hepatitis are Associated with Extrahepatic Cancers.

Ameer Abutaleb1, Jose Antonio Almario2, Saleh Alghsoon2, Ji Ae Yoon3, Kate Gheysens2, Shyam Kottilil4, Eleanor Wilson4.   

Abstract

BACKGROUND AND AIMS: An estimated 2.4 million Americans, including more than 150,000 veterans, are chronically infected with hepatitis C virus (HCV). HCV is estimated to cause roughly 25% of all hepatocellular carcinoma. Although its mechanism is unknown, developing evidence suggests that chronic HCV infection is also associated with the development of extrahepatic cancers (EHCs). This paper aims to assess the relationship of hepatic fibrosis and chronic HCV with the risk of developing EHC.
METHODS: We conducted a single-center retrospective chart review of 1541 patients linked to the hepatitis clinic at the Veterans Affairs (VA) Maryland Health Care System who underwent transient elastography for evaluation and management of liver disease from 2014 to 2018. Liver fibrosis was measured using ultrasound and transient elastography. Extrahepatic cancer and site was identified by a retrospective chart review.
RESULTS: In adjusted analysis of EHCs, advanced age (OR: 1.97, 95% CI: 1.30-3.04), and higher measured stiffness (OR 2.19, 95% CI: 1.32-3.64) were associated with an increased likelihood of developing EHC, controlling for HBV infection, HCV exposure, heavy alcohol use, and body mass index.
CONCLUSIONS: We observed a significant association between increasing age and increasing levels of liver fibrosis with increased risk of EHC, notably prostate, head and neck squamous cell, lung, and hematologic cancers.
© 2020 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CAP, Controlled attenuation parameter; DAA therapy; EHC, Extrahepatic cancer; HBV, Hepatitis B Virus; HCC, Hepatocellular carcinoma; HCV, Hepatitis C Virus; HIV, Human Immunodeficiency Virus; NASH, Nonalcoholic steatohepatitis; VA, Veterans Affairs; VAMHCS, Veterans Affairs Maryland Health Care System; extrahepatic cancer; hepatitis B virus; hepatitis C virus; liver fibrosis

Year:  2020        PMID: 33746444      PMCID: PMC7953003          DOI: 10.1016/j.jceh.2020.08.001

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  24 in total

Review 1.  Extrahepatic manifestations of HCV infection: facts and controversies.

Authors:  A L Zignego; C Bréchot
Journal:  J Hepatol       Date:  1999-08       Impact factor: 25.083

2.  Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people.

Authors:  Antonio De Vincentis; Luisa Costanzo; Umberto Vespasiani-Gentilucci; Antonio Picardi; Stefania Bandinelli; Luigi Ferrucci; Raffaele Antonelli Incalzi; Claudio Pedone
Journal:  Dig Liver Dis       Date:  2019-02-03       Impact factor: 4.088

3.  Hepatitis B and C Virus Infection and Risk of Pancreatic Cancer: A Population-Based Cohort Study (JPHC Study Cohort II).

Authors:  Sarah Krull Abe; Manami Inoue; Norie Sawada; Motoki Iwasaki; Taichi Shimazu; Taiki Yamaji; Shizuka Sasazuki; Eiko Saito; Yasuhito Tanaka; Masashi Mizokami; Shoichiro Tsugane
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-12-29       Impact factor: 4.254

4.  No difference between direct-acting antivirals for hepatitis C in hepatocellular carcinoma risk.

Authors:  Elijah J Mun; Pamela Green; Kristin Berry; George N Ioannou
Journal:  Eur J Gastroenterol Hepatol       Date:  2019-01       Impact factor: 2.566

5.  Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma.

Authors:  Ming-Chu Chang; Chien-Hung Chen; Ja-Der Liang; Yu-Wen Tien; Chiun Hsu; Jau-Min Wong; Yu-Ting Chang
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 6.  Diabetes mellitus and metformin in hepatocellular carcinoma.

Authors:  Koji Fujita; Hisakazu Iwama; Hisaaki Miyoshi; Joji Tani; Kyoko Oura; Tomoko Tadokoro; Teppei Sakamoto; Takako Nomura; Asahiro Morishita; Hirohito Yoneyama; Tsutomu Masaki
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

7.  Persistence of hepatocellular carcinoma risk in hepatitis C patients with a response to IFN and cirrhosis regression.

Authors:  Roberta D'Ambrosio; Alessio Aghemo; Maria Grazia Rumi; Elisabetta Degasperi; Angelo Sangiovanni; Marco Maggioni; Mirella Fraquelli; Riccardo Perbellini; William Rosenberg; Pierre Bedossa; Massimo Colombo; Pietro Lampertico
Journal:  Liver Int       Date:  2018-03-12       Impact factor: 5.828

Review 8.  Hepatitis C Associated B-cell Non-Hodgkin Lymphoma: Clinical Features and the Role of Antiviral Therapy.

Authors:  Syed Tasleem; Gagan K Sood
Journal:  J Clin Transl Hepatol       Date:  2015-06-15

9.  Risk of pancreatic cancer among individuals with hepatitis C or hepatitis B virus infection: a nationwide study in Sweden.

Authors:  J Huang; M Magnusson; A Törner; W Ye; A-S Duberg
Journal:  Br J Cancer       Date:  2013-10-31       Impact factor: 7.640

Review 10.  Hepatitis C Virus and Nonliver Solid Cancers: Is There an Association between HCV and Cancers of the Pancreas, Thyroid, Kidney, Oral Cavity, Breast, Lung, and Gastrointestinal Tract?

Authors:  Saad Qadwai; Tayyaba Rehman; Jonathan Barsa; Zeeshan Solangi; Edward Lebovics
Journal:  Gastroenterol Res Pract       Date:  2017-05-03       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.